Relay Therapeutics Net Tangible Assets

Relay Therapeutics (RLAY) currently reports a net tangible assets of $640M as of March 2026. That compares with $720M in the prior-year period — down 10.9% year over year. Use the charts on this page to explore Relay Therapeutics's net tangible assets history and peer comparisons.

Relay Therapeutics's net tangible assets decreased from $720M to $640M — a 10.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Relay Therapeutics reported $640M in net tangible assets as of March 2026. That compares with $720M in the prior-year period — down 10.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $640M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Relay Therapeutics, and consider following RLAY for alerts when major investors trade the stock.

Relay Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $640M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RLAY with unrelated industries.